Indian Sun Pharma Acquires American Argenon for $11.75 Billion
Indian pharmaceutical company Sun Pharma has announced its acquisition of American company Argenon in a fully cash deal valued at <strong>$11.75 billion</strong>. This acquisition aims to strengthen Sun Pharma's presence in the global market and expand its portfolio of drugs.